Showing results (21-30 of 154) with videos related to
Sort By:
Pageof 16
Journal of Molecular Histology|September 2, 2025
FAM49B mediates tumor progression and poor prognosis of gastric cancer through activating PI3K/AKT pathwayHuimin Yang, Yanxia Ji, Yingzhe Ju, et al.Evidence-Based Complementary and Alternative Medicine : Ecam|April 25, 2022
Bushen Jianpi Quyu Formula Alleviates Myelosuppression of an Immune-Mediated Aplastic Anemia Mouse Model via Inhibiting Expression of the PI3K/AKT/NF-κB Signaling PathwayHangchao Li, Lina Ji, Yingying Shen, et al.Journal of Cellular and Molecular Medicine|September 13, 2023
Prolonged haematologic toxicity in CAR-T-cell therapy: A reviewQi Liu, Tonglin Hu, Hangchao Li, et al.Translational Cancer Research|April 13, 2026
Vitamin B3 suppresses RasV12 -driven tumor growth in Drosophila via redox regulation, mitochondrial function, and autophagy activationYingying Shen, Yafang Tang, Xueting Fan, et al.Oncotarget|November 29, 2014
Antitumor activity of S116836, a novel tyrosine kinase inhibitor, against imatinib-resistant FIP1L1-PDGFRα-expressing cellsYingying Shen, Xiaomei Ren, Ke Ding, et al.International Journal of Molecular Sciences|February 26, 2022
Linking Multi-Omics to Wheat Resistance Types to Fusarium Head Blight to Reveal the Underlying MechanismsFan Wu, Yao Zhou, Yingying Shen, et al.Journal of Translational Medicine|April 14, 2025
Targeting kinases that regulate programmed cell death: a new therapeutic strategy for breast cancerYun Hong, Jun He, Dan Deng, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 18, 2011
Combinational RNAi gene therapy of hepatocellular carcinoma by targeting human EGFR and TERTYurong Hu, Yingying Shen, Baofang Ji, et al.European Journal of Haematology|May 19, 2023
Research progress on the hematopoietic microenvironment in aplastic anemiaHangchao Li, Chenjie Zhou, Yingying Shen, et al.Biochemical and Biophysical Research Communications|August 24, 2020
Preclinical evidence that MNK/eIF4E inhibition by cercosporamide enhances the response to antiangiogenic TKI and mTOR inhibitor in renal cell carcinomaSen Chen, Long Cui, Qiao Hu, et al.Pageof 16